Our team at Pure Med Spa Chicago helps clients with diet tips for weight loss medications , including sugar-control strategies to support long-term fat loss
Competitive Landscape: Some of the major market players in the GLP-1 receptor agonist industry include Amgen Inc., Eli Lilly and Company, Hanmi Pharm Co., Ltd., Jiangsu Hengrui Pharmaceuticals Co., Ltd., Novo Nordisk A/S, Paige Biomedicine (Suzhou) Co., Ltd., Sanofi S.A., among many others
Bei Fragen oder Zweifeln solltest du immer deinen Arzt oder einen Fachmann konsultieren
IGF-1 is what actually drives the shift in body composition
Clinical reference: In the STEP-1 trial, patients using semaglutide 2.4mg lost an average of 15% of body weight over 68 weeks
In type 2 diabetes trials (the SUSTAIN program), Ozempic produced an average weight loss of around 4.5 kg to 6.5 kg (roughly 10 to 14 lbs) over 52 weeks, depending on the dose